SE452322B - Kristallina 1,1-dioxopenicillanoyloximetyl-6-(d-alfa-amino-alfa-fenylacetamido) penicillanat-p-toluensulfonat-hydrat och farmaceutiska kompositioner derav - Google Patents

Kristallina 1,1-dioxopenicillanoyloximetyl-6-(d-alfa-amino-alfa-fenylacetamido) penicillanat-p-toluensulfonat-hydrat och farmaceutiska kompositioner derav

Info

Publication number
SE452322B
SE452322B SE8106404A SE8106404A SE452322B SE 452322 B SE452322 B SE 452322B SE 8106404 A SE8106404 A SE 8106404A SE 8106404 A SE8106404 A SE 8106404A SE 452322 B SE452322 B SE 452322B
Authority
SE
Sweden
Prior art keywords
tosylate
amino
penicillanate
phenylacetamido
crystalline
Prior art date
Application number
SE8106404A
Other languages
English (en)
Swedish (sv)
Other versions
SE8106404L (sv
Inventor
W O Godtfredsen
Daehne W Von
Original Assignee
Leo Pharm Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharm Prod Ltd filed Critical Leo Pharm Prod Ltd
Publication of SE8106404L publication Critical patent/SE8106404L/xx
Publication of SE452322B publication Critical patent/SE452322B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE8106404A 1980-10-31 1981-10-29 Kristallina 1,1-dioxopenicillanoyloximetyl-6-(d-alfa-amino-alfa-fenylacetamido) penicillanat-p-toluensulfonat-hydrat och farmaceutiska kompositioner derav SE452322B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8035156 1980-10-31

Publications (2)

Publication Number Publication Date
SE8106404L SE8106404L (sv) 1982-05-01
SE452322B true SE452322B (sv) 1987-11-23

Family

ID=10517019

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8106404A SE452322B (sv) 1980-10-31 1981-10-29 Kristallina 1,1-dioxopenicillanoyloximetyl-6-(d-alfa-amino-alfa-fenylacetamido) penicillanat-p-toluensulfonat-hydrat och farmaceutiska kompositioner derav

Country Status (26)

Country Link
US (1) US4831025A (xx)
JP (1) JPS57126493A (xx)
KR (1) KR870001982B1 (xx)
AT (1) AT373893B (xx)
AU (1) AU543870B2 (xx)
BE (1) BE890938A (xx)
CA (1) CA1180696A (xx)
CH (1) CH647527A5 (xx)
DE (1) DE3143219A1 (xx)
DK (1) DK154219C (xx)
ES (1) ES8206531A1 (xx)
FI (1) FI813331L (xx)
FR (1) FR2493322B1 (xx)
GB (1) GB2114969B (xx)
GR (1) GR75369B (xx)
IE (1) IE51640B1 (xx)
IL (1) IL64009A (xx)
IT (1) IT1193735B (xx)
LU (1) LU83727A1 (xx)
NL (1) NL8104938A (xx)
NO (1) NO813683L (xx)
NZ (1) NZ198622A (xx)
PH (1) PH17820A (xx)
PT (1) PT73913B (xx)
SE (1) SE452322B (xx)
ZA (1) ZA817091B (xx)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4432987A (en) * 1982-04-23 1984-02-21 Pfizer Inc. Crystalline benzenesulfonate salts of sultamicillin
PH20068A (en) * 1982-12-06 1986-09-18 Pfizer Process and intermediates for sultamicillin and analogs
KR910009271B1 (ko) * 1989-06-20 1991-11-08 김영설 1,1-디옥소페닐실라노일 옥시메틸 D-6-[α-(메틸렌아미노)페닐-아세트아미도]-페니실라네이트와 그의 파라-톨루엔술폰산염
ES2161602B1 (es) * 1999-04-08 2003-02-16 Asturpharma S A Sintesis de 6-(d-alfa-(bencilidenaminofenilacetamido))penicilanato de 1,1-dioxopenicilanoiloximetilo y analogos. nuevos intermedios para la sintesis de sultamicilina.
US6627222B2 (en) 2000-02-24 2003-09-30 Advancis Pharmaceutical Corp. Amoxicillin-dicloxacillin antibiotic composition
JP2003523372A (ja) * 2000-02-24 2003-08-05 アドバンシス ファーマシューティカル コーポレイション 抗生物質及び抗真菌剤組成物
US6565882B2 (en) 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
US6730320B2 (en) 2000-02-24 2004-05-04 Advancis Pharmaceutical Corp. Tetracycline antibiotic product, use and formulation thereof
US6667057B2 (en) 2000-02-24 2003-12-23 Advancis Pharmaceutical Corp. Levofloxacin antibiotic product, use and formulation thereof
US7025989B2 (en) * 2000-02-24 2006-04-11 Advancis Pharmaceutical Corp. Multiple-delayed released antibiotic product, use and formulation thereof
US6663890B2 (en) 2000-02-24 2003-12-16 Advancis Pharmaceutical Corp. Metronidazole antibiotic product, use and formulation thereof
US6667042B2 (en) 2000-02-24 2003-12-23 Advancis Pharmaceutical Corp. Fluroquinilone antibiotic product, use and formulation thereof
US6610328B2 (en) 2000-02-24 2003-08-26 Advancis Pharmaceutical Corp. Amoxicillin-clarithromycin antibiotic composition
US6632453B2 (en) 2000-02-24 2003-10-14 Advancis Pharmaceutical Corp. Ciprofoxacin-metronidazole antibiotic composition
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US6669948B2 (en) 2000-02-24 2003-12-30 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US6638532B2 (en) 2000-02-24 2003-10-28 Advancis Pharmaceutical Corp. Tetracycline—doxycycline antibiotic composition
US6991807B2 (en) * 2000-02-24 2006-01-31 Advancis Pharmaceutical, Corp. Antibiotic composition
US6623758B2 (en) 2000-02-24 2003-09-23 Advancis Pharmaceutical Corp. Cephalosporin-metronidazole antibiotic composition
WO2001062229A1 (en) * 2000-02-24 2001-08-30 Advanced Pharma, Inc. Therapeutic product, use and formulation thereof
US6663891B2 (en) 2000-02-24 2003-12-16 Advancis Pharmaceutical Corp. Erythromyacin antibiotic product, use and formulation thereof
US7105174B2 (en) * 2000-10-13 2006-09-12 Advancis Pharmaceutical Corporation Multiple-delayed release anti-neoplastic product, use and formulation thereof
US7074417B2 (en) * 2000-10-13 2006-07-11 Advancis Pharmaceutical Corporation Multiple-delayed release anti-viral product, use and formulation thereof
US7157095B2 (en) * 2000-10-13 2007-01-02 Advancis Pharmaceutical Corporation Multiple-delayed release antifungal product, use and formulation thereof
US6541014B2 (en) 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
US20020197314A1 (en) * 2001-02-23 2002-12-26 Rudnic Edward M. Anti-fungal composition
US20040114368A1 (en) * 2002-12-13 2004-06-17 Shyu Shing Jy Light device having rotatable or movable view
US20040265323A1 (en) * 2003-05-16 2004-12-30 Mccormick Beth A. Compositions comprising pathogen elicited epithelial chemoattractant (eicosanoid hepoxilin A3), inhibitors thereof and methods of use thereof
EP1648418A4 (en) 2003-07-21 2011-11-16 Middlebrook Pharmaceuticals Inc ANTIBIOTIC PRODUCT, ITS USE AND FORMULATION
AU2004258953B2 (en) 2003-07-21 2011-02-10 Shionogi, Inc. Antibiotic product, use and formulation thereof
US8313776B2 (en) 2003-07-21 2012-11-20 Shionogi Inc. Antibiotic product, use and formulation thereof
EP1653925A1 (en) 2003-08-11 2006-05-10 Advancis Pharmaceutical Corporation Robust pellet
AU2004264356B2 (en) 2003-08-12 2011-01-27 Shionogi, Inc. Antibiotic product, use and formulation thereof
JP5686494B2 (ja) 2003-08-29 2015-03-18 シオノギ インコーポレイテッド 抗生物質製剤、その使用法及び作成方法
WO2005027877A1 (en) 2003-09-15 2005-03-31 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
JP2008505124A (ja) 2004-07-02 2008-02-21 アドバンシス ファーマスーティカル コーポレイション パルス送達用錠剤
WO2007004239A1 (en) * 2005-07-06 2007-01-11 Morepen Laboratories Limited New polymorphic form of sultamicillin tosylate and a process therefor
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8778924B2 (en) 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8299052B2 (en) * 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
AU2013290827B2 (en) 2012-07-17 2018-10-18 Elanco New Zealand Injectable antibiotic formulations and their methods of use
EP2874624B8 (en) 2012-07-17 2019-10-02 Bayer New Zealand Limited Injectable antibiotic formulations and their methods of use
US11116737B1 (en) 2020-04-10 2021-09-14 University Of Georgia Research Foundation, Inc. Methods of using probenecid for treatment of coronavirus infections

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1532222A (fr) * 1963-10-28 1968-07-12 Bristol Myers Co Procédé de préparation de dérivés de la pénicilline
BE881675A (fr) * 1979-02-13 1980-08-12 Leo Pharm Prod Ltd B-lactames derives de l'acide penicillanique leur preparation et leurs utilisations therapeutiques
IE49880B1 (en) * 1979-02-13 1986-01-08 Leo Pharm Prod Ltd Penicillin derivatives
US4244951A (en) * 1979-05-16 1981-01-13 Pfizer Inc. Bis-esters of methanediol with penicillins and penicillanic acid 1,1-dioxide
IE51516B1 (en) * 1980-10-06 1987-01-07 Leo Pharm Prod Ltd 1,1-dioxapenicillanoyloxymethyl 6-(d-alpha-amino-alpha-phenylacetamido)penicillanate napsylate

Also Published As

Publication number Publication date
JPH027957B2 (xx) 1990-02-21
FI813331L (fi) 1982-05-01
IL64009A (en) 1984-09-30
ES506751A0 (es) 1982-08-16
KR870001982B1 (ko) 1987-10-24
SE8106404L (sv) 1982-05-01
KR830007671A (ko) 1983-11-04
IL64009A0 (en) 1982-01-31
DK472181A (da) 1982-05-01
PT73913B (en) 1984-05-29
ES8206531A1 (es) 1982-08-16
AU7636581A (en) 1982-05-06
US4831025A (en) 1989-05-16
GB2114969A (en) 1983-09-01
IT1193735B (it) 1988-08-24
ZA817091B (en) 1982-10-27
DE3143219C2 (xx) 1990-05-17
NL8104938A (nl) 1982-05-17
JPS57126493A (en) 1982-08-06
CA1180696A (en) 1985-01-08
IE812361L (en) 1982-04-30
GR75369B (xx) 1984-07-13
DK154219C (da) 1989-03-20
BE890938A (fr) 1982-04-30
IT8168383A0 (it) 1981-10-23
LU83727A1 (fr) 1982-05-07
GB2114969B (en) 1985-02-20
NZ198622A (en) 1985-07-12
PH17820A (en) 1985-01-07
DE3143219A1 (de) 1982-08-12
ATA447781A (de) 1983-07-15
NO813683L (no) 1982-05-03
AU543870B2 (en) 1985-05-09
AT373893B (de) 1984-02-27
IE51640B1 (en) 1987-01-21
DK154219B (da) 1988-10-24
FR2493322A1 (fr) 1982-05-07
CH647527A5 (de) 1985-01-31
FR2493322B1 (fr) 1986-06-13
PT73913A (en) 1981-11-01

Similar Documents

Publication Publication Date Title
SE452322B (sv) Kristallina 1,1-dioxopenicillanoyloximetyl-6-(d-alfa-amino-alfa-fenylacetamido) penicillanat-p-toluensulfonat-hydrat och farmaceutiska kompositioner derav
JPH0314811B2 (xx)
CN1382682A (zh) 2－(α－羟基戊基)苯甲酸盐及其制法和用途
JPS6020394B2 (ja) 抗生物質の製造方法
JPS60174783A (ja) 新規８α‐アシルアミノエルゴリン類
SE452323B (sv) Kristallint 1,1-dioxopenicillanoyloximetyl-6-(d-alfa-amino-alfa-fenylacetamido) penicillanat-2-naftensulfonat och farmaceutiska kompositioner derav
CN1064681C (zh) 杂环化合物
KR870000291B1 (ko) 결정상 벤조티아진 디옥사이드 염의 제조방법
RU2515557C9 (ru) Фармацевтическая соль 8-метил-7-[5-метил-6-(метиламино)-3-пиридинил]-1-циклопропил-4-оксо-1,4-дигидро-3-хинолинкарбоновой кислоты, ее содержащая фармацевтическая композиция, лекарственное средство и способ лечения или профилактики бактериальных инфекций с помощью вышеуказанной соли
ZA200508640B (en) Crystal of benzimidazole derivative and process for producing the same
JPS6011040B2 (ja) 抗菌剤類の製法
JPH10195076A (ja) 結晶形態のカルバペネム化合物
US4464379A (en) Indol acetic acid derivatives and anti-inflamatory and related uses thereof
GB2084572A (en) 1,1-Dioxopenicillanoyloxymethyl 6-(D- alpha -amino- alpha -phenylacetamido)penicillanate napsylate
JP3148235B2 (ja) 抗菌性ペネム化合物
US3253990A (en) N-methyl glucammonium salicylate and uses therefor
JP3242975B2 (ja) 消化管運動機能改善剤
JP2739328B2 (ja) ベンズイミダゾール化合物の精製方法
JP3274855B2 (ja) 抗菌性ペネム化合物
JPH09124653A (ja) 水和物結晶及びその製造方法
HU203869B (en) Process for producing salts ofnew acrylic acid derivatives and pharmaceutical compositions containing them
IE43950B1 (en) New 6-amidinopenicillanic acid derivatives
JPS63190886A (ja) ２−アミノ−１，３，４−チアジアゾ−ル誘導体および該誘導体を有効成分とする抗潰瘍剤

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8106404-0

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8106404-0

Format of ref document f/p: F